KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Receivables - Other: 2021-2024

Historic Receivables - Other for Dynavax Technologies (DVAX) over the last 4 years, with Dec 2024 value amounting to $1.6 million.

  • Dynavax Technologies' Receivables - Other fell 50.49% to $962,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $962,000, marking a year-over-year decrease of 50.49%. This contributed to the annual value of $1.6 million for FY2024, which is 58.61% down from last year.
  • Per Dynavax Technologies' latest filing, its Receivables - Other stood at $1.6 million for FY2024, which was down 58.61% from $3.9 million recorded in FY2023.
  • Over the past 5 years, Dynavax Technologies' Receivables - Other peaked at $72.0 million during FY2022, and registered a low of $1.6 million during FY2024.
  • Moreover, its 3-year median value for Receivables - Other was $3.9 million (2023), whereas its average is $25.8 million.
  • In the last 5 years, Dynavax Technologies' Receivables - Other climbed by 15.10% in 2022 and then crashed by 94.54% in 2023.
  • Over the past 4 years, Dynavax Technologies' Receivables - Other (Yearly) stood at $62.5 million in 2021, then grew by 15.10% to $72.0 million in 2022, then tumbled by 94.54% to $3.9 million in 2023, then plummeted by 58.61% to $1.6 million in 2024.